OtherClinical Investigations (Human)
Open Access
PET-based dosimetry of [68Ga]Ga-NODAGA-exendin-4 in humans, a tracer for beta cell imaging.
Marti Boss, Mijke Buitinga, Tom JP Jansen, Maarten Brom, Eric P Visser and Martin Gotthardt
Journal of Nuclear Medicine September 2019, jnumed.119.228627; DOI: https://doi.org/10.2967/jnumed.119.228627
Marti Boss
Radboud University Medical Center, Netherlands
Mijke Buitinga
Radboud University Medical Center, Netherlands
Tom JP Jansen
Radboud University Medical Center, Netherlands
Maarten Brom
Radboud University Medical Center, Netherlands
Eric P Visser
Radboud University Medical Center, Netherlands
Martin Gotthardt
Radboud University Medical Center, Netherlands

Data supplements
Supplemental Data
Files in this Data Supplement:
In this issue
Journal of Nuclear Medicine
Vol. 66, Issue 2
February 1, 2025
PET-based dosimetry of [68Ga]Ga-NODAGA-exendin-4 in humans, a tracer for beta cell imaging.
Marti Boss, Mijke Buitinga, Tom JP Jansen, Maarten Brom, Eric P Visser, Martin Gotthardt
Journal of Nuclear Medicine Sep 2019, jnumed.119.228627; DOI: 10.2967/jnumed.119.228627
Jump to section
Related Articles
Cited By...
- Glucagonlike Peptide-1 Receptor Imaging in Individuals with Type 2 Diabetes
- Glucagonlike Peptide-1 Receptor Imaging in Individuals with Type 2 Diabetes
- 68Ga-NODAGA-Exendin-4 PET Scanning for Focal Congenital Hyperinsulinism: Need for Replication
- 68Ga-NODAGA-Exendin-4 PET/CT Improves the Detection of Focal Congenital Hyperinsulinism